Torrent Pharmaceuticals on Friday reported a 52% increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023.
The drug firm had reported a net profit of Rs 292 crore in the October-December period of the last fiscal.
Its revenue increased by 10% to Rs 2,732 crore in the third quarter compared to Rs 2,491 crore in the year-ago period, Torrent Pharmaceuticals said in a statement.
The company said its domestic business revenues increased 12% year-on-year to Rs 1,415 crore in the October-December quarter this year.
Brazil's business grew by 26% to Rs 312 crore, while the U.S. business expanded by 6% to Rs 274 crore in the third quarter.
German revenues for the October-December period witnessed a 12% growth to Rs 270 crore in the December 2023 quarter.
Shares of the company on Friday ended 0.51% up at Rs 2,524.70 apiece on the BSE.
RECOMMENDED FOR YOU
Swiggy Q2 Results: Net Loss Widens Despite Over 50% Jump In Revenue — Key Takeaways
Bata India Q2 Results: Net Profit, Revenue Slump
CCI Clears Torrent Pharma's Proposal To Buy Stake In JB Chemicals
P N Gadgil Jewellers Records 65% Jump In Navratri-Dussehra Festive Sales
POPULAR